[1]
“Platelet-Derived Microparticle Count in β-Thalassemia Patients with Direct Labeling Monoclonal Antibody CD62P and CD41”, MKB, vol. 52, no. 2, pp. 92–98, Jun. 2020, doi: 10.15395/mkb.v52n2.1836.